Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

No quarrel with that.
A Tangent: A presumably educational story not requested and offered as demonstration that IPIX is not my first cow in a ditch, as some say in my neck of the woods.

Late 2016 I watched Olaratumab jump from phase 2 to $20k per month treatment for STS via AA. Nice memory: I did my DD, concluded that this time Lilly's science was not just valid, but exceptional and thought that AA had a very good change to happen. So-called PRO:s laughed and countered that Olaratumab's approval will be long ways off. That prediction did not make me rich, BTW. AA did not even change SP's downward direction.

But they still call phase 2 mid-stage and phase 3 late stage.